Probiotic Escherichia coli Nissle 1917 activates DC and prevents house dust mite allergy through a TLR4-dependent pathway

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 1995-2005

  Adam, Emmanuelle ^a   Delbrassine, Laurence ^a   Bouillot, Céline ^a   Reynders, Virginie ^a   Mailleux, Anne Catherine ^b   Muraille, Eric ^a   Jacquet, Alain ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Adjuvant; Escherichia coli nissle; House dust mite allergy; TLR4

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; I KAPPA B; IMMUNOGLOBULIN E; INTERLEUKIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PROBIOTIC AGENT; PRODER P 1; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ARTHROPOD PROTEIN; CYSTEINE PROTEINASE; CYTOKINE; DERMATOPHAGOIDES PTERONYSSINUS ANTIGEN P 1; DIFFERENTIATION ANTIGEN; HOUSE DUST ALLERGEN; LEUKOCYTE ANTIGEN;

ALLERGIC REACTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG ACTIVITY; ESCHERICHIA COLI; FEMALE; HOUSE DUST ALLERGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SIGNAL TRANSDUCTION; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL DIFFERENTIATION; DESENSITIZATION; DISEASE MODEL; DRUG EFFECTS; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PYROGLYPHIDAE; SECRETION (PROCESS);

ANIMALS; ANTIGENS, CD; ANTIGENS, DERMATOPHAGOIDES; ANTIGENS, DIFFERENTIATION; ARTHROPOD PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; CYTOKINES; DENDRITIC CELLS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; HUMANS; HYPERSENSITIVITY; MICE; MICE, INBRED BALB C; PROBIOTICS; PYROGLYPHIDAE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 77954138397     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939913     Document Type: Article

References (43)

1. Mercenier, A., Pavan, S. and Pot, B., Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr. Pharm. Des. 2003. 9: 175-191.
2. Hisbergues, M., Magi, M., Rigaux, P., Steuve, J., Garcia, L., Goudercourt, D., Pot, B. et al., A In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Clin. Exp. Allergy 2007. 37: 1286-1295.
3. Rigaux, P., Daniel, C., Hisbergues, M., Muraille, E., Hols, P., Pot, B., Pestel, J. et al., Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 2009. 64: 406-414.
4. Ryu, Y. H., Baik, J. E., Yang, J. S., Kang, S. S., Im, J., Yun, C. H., Kim, D. W. et al., Differential immunostimulatory effects of Gram-positive bacteria due to their lipoteichoic acids. Int. Immunopharmacol. 2009. 9: 127-133.
5. Chung, Y.W., Choi, J. H., Oh, T. Y., Eun, C. S. and Han, D. S., Lactobacillus casei prevents the development of dextran sulphate sodium-induced colitis in Toll-like receptor 4 mutant mice. Clin. Exp. Immunol. 2008. 151: 182-189.
6. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., Raupach, B. et al., Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways.. Infect. Immun. 2006. 74: 4075-4082.
7. Vijay-Kumar, M., Aitken, J. D. and Gewirtz, A. T., Toll like receptor-5: protecting the gut from enteric microbes. Semin. Immunopathol. 2008. 30: 11-21.
8. Hall, J. A., Bouladoux, N., Sun, C. M.,Wohlfert, E. A., Blank, R. B., Zhu, Q., Grigg, M. E. et al., Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008. 29: 637-649.
9. Penders, J., Stobberingh, E. E., van den Brandt, P. A. and Thijs, C., The role of the intestinal microbiota in the development of atopic disorders. Allergy 2007. 62: 1223-1236.
10. .Forsythe, P., Inman, M. D. and Bienenstock, J., Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am. J. Respir. Crit. Care Med. 2007. 175: 561-569.
11. Kalliomaki, M., Salminen, S., Poussa, T. and Isolauri, E., Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2007. 119: 1019-1021.
12. Daniel, C., Repa, A., Wild, C., Pollak, A., Pot, B., Breiteneder, H., Wiedermann, U. et al., Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1. Allergy 2006. 61: 812-829.
13. Repa, A., Grangette, C., Daniel, C., Hochreiter, R., Hoffmann- Sommergruber, K., Thalhamer, J., Kraft, D. et al., Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy. Vaccine 2003. 22: 87-95.
14. Mastrangeli, G., Corinti, S., Butteroni, C., Afferni, C., Bonura, A., Boirivant, M., Colombo, P. et al., Effects of live and inactivated VSL#3 probiotic preparations in the modulation of in vitro and in vivo allergen-induced Th2 responses. Int. Arch. Allergy Immunol. 2009. 150: 133-143.
15. Grozdanov, L., Raasch, C., Schulze, J., Sonnenborn, U., Gottschalk, G., Hacker, J. and Dobrindt, U., Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917. J. Bacteriol. 2004. 186: 5432-5441.
16. Schultz, M., Clinical use of E. coli Nissle 1917 in inflammatory bowel disease. Inflamm. Bowel Dis. 2008. 14: 1012-1018.
17. Rolfe, V. E., Fortun, P. J., Hawkey, C. J. and Bath-Hextall, F., Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst. Rev. 2006. 18: CD004826.
18. Henker, J., Müller, S., Laass, M.W., Schreiner, A. and Schulze, J., Probiotic Escherichia coli Nissle 1917 (EcN) for successful remission maintenance of ulcerative colitis in children and adolescents: an open-label pilot study. Z. Gastroenterol. 2008. 46: 874-875.
19. Fink, L. N. and Frøkiaer, H., Dendritic cells from Peyer's patches and mesenteric lymph nodes differ from spleen dendritic cells in their response to commensal gut bacteria. Scand. J. Immunol. 2008. 68: 270-279.
20. Guzy, C., Paclik, D., Schirbel, A., Sonnenborn, U., Wiedenmann, B. and Sturm, A., The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways. Int. Immunol. 2008. 20: 829-840.
21. .Helwig, U., Lammers, K. M., Rizzello, F., Brigidi, P., Rohleder, V., Caramelli, E., Gionchetti, P. et al., Lactobacilli, bifidobacteria and E coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J. Gastroenterol. 2006. 12: 5978-5986.
22. Schlee, M.,Wehkamp, J., Altenhoefer, A., Oelschlaeger, T. A., Stange, E. F. and Fellermann, K., Induction of human beta-defensin 2 by the probiotic Escherichia coli Nissle 1917 is mediated through flagellin. Infect. Immun. 2007. 75: 2399-2407.
23. Pålsson-McDermott, E. M. and O'Neill, L. A., Signal transduction by the lipopolysaccharide receptor, Toll-like receptor-4. Immunology 2004. 113: 153-162.
24. Hurley, J. C., Endotoxemia: methods of detection and clinical correlates. Clin. Microbiol. Rev. 1995. 8: 268-292.
25. Cross, M. L., Ganner, A., Teilab, D. and Fray, L. M., Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria. FEMS Immunol. Med. Microbiol. 2004. 42: 173-180.
26. Grozdanov, L., Zähringer, U., Blum-Oehler, G., Brade, L., Henne, A., Knirel, Y. A., Schombel, U. et al., A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J. Bacteriol. 2002. 184: 5912-5925.
27. Nagaoka, K., Takahara, K., Tanaka, K., Yoshida, H., Steinman, R. M., Saitoh, S., Akashi-Takamura, S. et al., Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gramnegative bacteria. Int. Immunol. 2005.17:827-836.
28. Rasche, C., Wolfram, C., Wahls, M. and Worm, M., Differential immunomodulating effects of inactivated probiotic bacteria on the allergic immune response. Acta Derm. Venereol. 2007. 87: 305-311.
29. Ma, W., Lim, W., Gee, K., Aucoin, S., Nandan, D., Kozlowski, M., Diaz-Mitoma, F. et al., The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 2001. 276: 13664-13674.
30. Numazaki, M., Kato, C., Kawauchi, Y., Kajiwara, T., Ishii, M. and Kojima, N., Cross-linking of SIGNR1 activates JNK and induces TNF-alpha production in RAW264.7 cells that express SIGNR1. Biochem. Biophys. Res. Commun. 2009. 386: 202-206.
31. Dong, Z., Yang, Z. andWang, C., Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway. Am. J. Rhinol. 2005. 19: 236-239.
32. Rampey, A. M., Lathers, D. M., Woodworth, B. A. and Schlosser, R. J., Immunolocalization of dendritic cells and pattern recognition receptors in chronic rhinosinusitis. Am. J. Rhinol. 2007. 21: 117-121.
33. Hufnagl, K., Wagner, B., Winkler, B., Baier, K., Hochreiter, R., Thalhamer, J., Kraft, D. et al., Induction of mucosal tolerance with recombinant Hev b 1 and recombinant Hev b 3 for prevention of latex allergy in BALB/c mice. Clin. Exp. Immunol. 2003.133: 170-176.
34. Repa, A., Kozakova, H., Hudcovic, T., Stepankova, R., Hrncir, T., Tlaskalova-Hogenova, H., Pollak, A. et al., Susceptibility to nasal and oral tolerance induction to the major birch pollen allergen Bet v 1 is not dependent on the presence of the microflora. Immunol. Lett. 2008. 117: 50-56.
35. Bickert, T., Trujillo-Vargas, C. M., Duechs, M., Wohlleben, G., Polte, T., Hansen, G., Oelschlaeger, T. A. et al., Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways. Int. Arch. Allergy Immunol. 2009. 149: 219-230.
36. Schultz, M., Strauch, U. G., Linde, H. J., Watzl, S., Obermeier, F., Göttl, C., Dunger, N. et al., Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin. Diagn. Lab. Immunol. 2004. 11: 372-378.
37. Borchers, A. T., Selmi, C., Meyers, F. J., Keen, C. L. and Gershwin, M. E., Probiotics and immunity. J. Gastroenterol. 2009. 44: 26-46.
38. Grabig, A., Paclik, D., Guzy, C., Dankof, A., Baumgart, D. C., Erckenbrecht, J., Raupach, B. et al., Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect. Immun. 2006. 74: 4075-4082.
39. Zoumpopoulou, G., Tsakalidou, E., Dewulf, J., Pot, B. and Grangette, C., Differential crosstalk between epithelial cells, dendritic cells and bacteria in a co-culture model. Int. J. Food Microbiol. 2009. 131: 40-51.
40. Eisenbarth, S. C., Piggott, D. A., Huleatt, J. W., Visintin, I., Herrick, C. A. and Bottomly, K., Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 2002. 196: 1645-1651.
41. Piggott, D. A., Eisenbarth, S. C., Xu, L., Constant, S. L., Huleatt, J. W., Herrick, C. A. and Bottomly, K., MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J. Clin. Invest. 2005.115: 459-467.
42. Massaer, M., Mazzu, P., Haumont, M., Magi, M., Daminet, V., Bollen, A. and Jacquet, A., High-level expression in mammalian cells of recombinant house dust mite allergen ProDer p 1 with optimized codon usage. Int. Arch. Allergy Immunol. 2001. 125: 32-43.
43. Tanaka, T., Legat, A., Adam, E., Steuve, J., Gatot, J. S., Vandenbranden, M., Ulianov, L. et al., DiC14-amidine cationic liposomes stimulate myeloid dendritic cells through Toll-like receptor 4. Eur. J. Immunol. 2008. 38: 1351-1357.